Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Advanced Medicine

The Hype, Hope and Reality of Personalization

Cell-based therapies have been celebrated as a new approach to healthcare because of their potential to treat a wide variety of unmet clinical needs – from cancer to arthritis to spinal cord injury. Cell therapy involves administering living cells to a patient with the aim of replacing missing or damaged cell types, potentially treating the underlying cause of a disease. Some cell therapies have already been approved by regulators and with further research taking place, we can expect to see many more in the future.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Authors

Behzad Mahdavi

VP of Strategic Innovation & Alliance. Uwe Gottschalks, Chief Technology Officer both at Lonza


Uwe Gottschalks

Chief Technology Officer both at Lonza


Nuala Trainor

Director of Biological Progams


Tim Smith

CEO at Octance Biotech

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register